illuminem logo
illuminem logo
  • Rankings
  • Use Cases
  • Pricing
  • Media
  • More
illuminem logo

About illuminem

AboutCareersBecome a Thought Leader

Advertising

Advertise with usPromote EventsOur Reach

Support

FAQsContact Us
Terms & Privacy Policy

© 2026 illuminem. All rights reserved. Various trademarks held by their owners.

  1. Home
  2. ›
  3. Industries
  4. ›
  5. hospital & health care
  6. ›
  7. SciBase
Company logo

SciBase | Sustainability Performance

https://scibase.com
Linkedin

SciBase Holding AB focuses on medical technology, specifically in the area of skin cancer detection. The company develops diagnostic tools aimed at improving the accuracy and efficiency of dermatological examinations through innovative solutions.

1998

Sweden

11 - 50 employees

Medical Device

$1M - 10M in revenue

Not profitable

Submit or report inaccurate dataDownload Company Insights

Sustainability Ranking & Industry Benchmark

#5398
Overall
#310
in Sweden
#77
in Medical Device

Sustainability Maturity

​​0123456789​​%

Sustainability Intent

Available in
Scale package

Access
​​0123456789​​%

Beyond Top 100

Overview
Governance
TargetsESG scores and Exclusions
Financial Data
Business performanceCapital & innovationAnalyst projections

View similiar companies


Company logo
Moberg Pharma

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
Recipharm

Sweden, Hospital & Health Care, Pharmaceuticals


Company logo
RaySafe

Sweden, Hospital & Health Care, Medical Device

Market cap

69.8B $, 2026▼98.8% YoY

Revenue

4.1M $, 2025▲27.5% YoY

R&D intensity

57.5% 2025

Controversy level


Very Low
Low
Noticeable
High
Severe
Download Controversy Analysis
  • SciBase reported sustained losses during commercialization of its skin cancer diagnostic device.
Powered by illuminem

Market cap

69.8B $, 2026▼98.8% YoY

Revenue

4.1M $, FY2025▲27.5% YoY

EBITDA

-8.8M $, FY2025▼9.1% YoY

Operating margin

-214% Industry: -136▼5.9% YoY

Revenue & EBITDA

$4.1MFY2025 revenue

Total Annual
Revenue & EBITDA
($ B)

Annual revenue
EBITDA
3 year change
Powered by illuminem

Margin trends


Margin as % of revenue

Gross margin
Operating margin
Net margin

Powered by illuminem

Free cashflow

-5.9M 2024▲9.4% YoY

Capex

0.0 2024▼NaN% YoY

Debt/equity ratio

3.4 Industry: 1▼NaN% YoY

R&D intensity

57.5%FY2025

R&D as % of revenue

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Return on invested capital

-299.0%FY2026

Return on invested capital (ROIC)
Industry benchmark

Powered by illuminem

Analyst revenue estimates & actuals


Analyst consensus vs actuals
($ B)

Actual revenue
Consensus estimates
Estimate only

0.0

▼ 6.3%

2023

0.0

▲ 0.5%

2024

0.0

▲ 1.0%

2025

0.2

2029

Powered by illuminem

Environmental policy coverage

Carbon reduction policy

Not available

Human rights policy

Not available

Recycling policy

Not available

Workplace health & safety policy

Not available

40%
Independent Directors

4 out of 10 incl. management

Powered by illuminem

Overall score

30

Environment

15

Social

39

Governance

35

Exclusion screening

Adult content

Not available

Alcoholic

Not available

Animal testing

Available

Firearms

Not available

Tobacco

Not available

Gambling

Not available

Nuclear

Not available

Powered by illuminem

Reporting

sustainability report symbol

Sustainability Report

Available

Sustainability employees



    Available in
    Scale package

    Access
  • Email

  • Email